Skip to main content

Table 3 Adjusted Odds Ratio and 95% Confidence Intervals (CI) for logistic regression models predicting intention to screen by women in 5 European countries responding to the survey on mammography screening, 2021 (n = 1180)

From: Factors affecting intention to screen after being informed of benefits and harms of breast cancer screening: a study in 5 European countries in 2021

Components Model 1a,b Model 2c,d  
Neither more nor less likely to participate next time invited/referred for breast cancer screening More likely to participate next time
invited/referred for breast cancer
screening
Neither more nor less likely to participate next time invited/referred for breast cancer screening More likely to participate next time invited/referred for breast cancer screening
Adjusted OR 95% CI Adjusted OR 95% CI Adjusted OR 95% CI Adjusted OR 95% CI
Age
 50–59 y . . . . . . . .
 60+ y . . . . .837 (.458–1.531) .505 (.274–.931)
Income
 €20,000–€39,999 . . . . . . . .
  < €19,999 . . . . 1.446 (.663–3.151) 1.145 (.522–2.515)
 €40,000–€59,999 . . . . 1.169 (.456–2.997) .788 (.303–2.044)
 €60,000–€79,999 . . . . .742 (.206–2.673) .419 (.114–1.538)
 €80,000+ . . . . 2.967 (.322–27.361) 2.585 (.276–24.239)
Prefer not to say . . . . 1.683 (.706–4.012) 1.154 (.479–2.782)
HLS6 Score .911 (.769–1.078) .847 (.714–1.004) .903 (.759–1.073) .843 (.708–1.004)
Screening History
 Not participated . . . . . .   .
 Participated .812 (.387–1.703) 1.780 (.803–3.947) .778 (.366–1.657) 1.883 (.833–4.257)
Health Knowledge
 Incorrect . . . . . . . .
 Correct .622 (.302–1.284) .991 (.472–2.078) .618 (.298–1.283) 1.061 (.502–2.242)
Social Norm
 Agree . . . . . . . .
 Disagree .323 (.153–.686) .345 (.162–.734) .322 (.150–.691) .351 (.163–.758)
 Unsure .754 (.364–1.560) .452 (.216–.946) .766 (.369–1.594) .447 (.212–.940
Perceived Behavioural Control
 Easy . . . . . . . .
 Difficult .237 (.103–.544) .140 (.059–.335) .217 (.093–.504) .120 (.049–.290)
 Unsure .201 (.094–.430) .142 (.066–.305) .194 (.090–.421) .132 (.060–.288)
Perceived Susceptibility
 Unsure . . . . . . . .
 Agree .810 (.215–3.048) 1.877 (.511–6.889) .864 (.225–3.316) 1.901 (.506–7.138)
 Disagree .729 (.390–1.364) .457 (.242–.865) .696 (.369–1.310) .435 (.228–.830)
Perceived Barriers
 Disagree . . . . . . . .
 Agree .338 (.166–.692) .175 (.084–.362) .347 (.169–.711) .183 (.088–.382)
 Unsure .638 (.280–1.454) .508 (.222–1.161) .643 (.279–1.481) .544 (.235–1.259)
  1. a Model 1 result = Negelkerke R2 .201
  2. b Model 1 reference category: Less likely to participate next time invited/referred for breast cancer screening
  3. c Model 2 result = Negelkerke R2 .224
  4. d Model 2 reference category: Less likely to participate next time invited/referred for breast cancer screening